Age-related macular degeneration (AMD) is a progressive eye condition that is characterised by the gradual deterioration of the macula, which is the area of the retina responsible for central vision.
AMD is the most common cause of significant irreversible vision loss among the elderly. In the seven major pharmaceutical markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan) in 2016, GlobalData epidemiologists found that the majority of diagnosed incident cases of AMD occurred in women (65.76%), with 7,400,411 cases, while men accounted for 34.24%, with 3,852,822 cases (as shown in Figure 1). According to the American Medical Macular Degeneration Foundation and the National Institute of Health’s National Eye Institute, women are more susceptible to AMD than men because they live approximately 5% longer than men. As the risk for developing AMD dramatically increases with advancing age, GlobalData epidemiologists expect that the burden attributed to AMD will increase considerably over the next few decades, given the increasing aging population worldwide.
GlobalData (2017). EpiCast Report: Age-Related Macular Degeneration – Epidemiology Forecast to 2026, November 2017, GDHCER170-17